Back To Schedule
Tuesday, June 29 • 4:00pm - 5:00pm
#263 SL: Pandemic Preparedness: Accelerating Treatments to Overcome Antimicrobial Resistance

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Advanced
CE: ACPE 1.00 Knowledge UAN: 0286-0000-21-594-L04-P; CME 1.00; IACET 1.00; RN 1.00

Antimicrobial resistance (AMR) is a threat to global health. Reactive efforts to address AMR risks lives, economies, and security. A proactive preparedness model relies on innovation in development and regulatory pathways.

Learning Objectives

Review the current regulatory framework in the context of increasing AMR; Discuss regulator’s role in ensuring development feasibility; Identify areas for improvement.


Lisa Wittmer, PhD


Pandemic Preparedness: Accelerating Treatments to Overcome Antimicrobial Resistance
Sumathi Nambiar, MD, MPH

EMA Update
Marco Cavaleri, PhD

Paul Christopher McGovern


Lisa Wittmer

President, Theorogen Consulting, United States
avatar for Marco Cavaleri

Marco Cavaleri

Head of Health Threats and Vaccines Strategy, European Medicines Agency, Netherlands
Head of Anti-infectives and Vaccines, European Medicines Agency (2009-present) Therapeutic Group Leader for Anti-infectives, European Medicines Agency (2008-2009) Associate Scientific Director, Cosmo Pharmaceuticals S.p.A., Lainate, Italy (2008) Scientific Administrator, European... Read More →

Paul McGovern

Vice President, Medical Sciences, Venatorx Pharmaceuticals, Inc., United States
avatar for Sumathi Nambiar

Sumathi Nambiar

Director, Anti-Infective Products, OND, CDER, FDA, United States

Tuesday June 29, 2021 4:00pm - 5:00pm EDT
TBD Virtual Event Horsham, PA 19044
  09: Regulatory, Session
  • Beginner Intermediate
  • Featured Topics What's Next
  • Credit Type ACPE, CME, IACET, RN
  • Student Programming What's Next
  • Featured Topics What's Next
  • Tags Session